Sopan Pharmaceuticals Limited Opens IPO for Foreign Nepalese Immigrants From Today
Summary
Sopan Pharmaceuticals Limited has opened its IPO for Nepalese citizens working abroad, offering 4,29,000 shares from 9th to 12th Chaitra 2082, with potential extension until Chaitra 23 if undersubscribed.
Key Points
- Sopan Pharmaceuticals Limited has started issuing its IPO specifically for Nepalese citizens working abroad from 9th to 12th Chaitra 2082.
- The IPO offers 4,29,000 units of shares reserved for overseas Nepalese with a minimum application of 10 units and a maximum of 11,000 units.
- The company's total issued capital is Rs. 1.71 Arba with 25% (42,90,000 shares) issued to the public including reserved allocations for employees and mutual funds.
- CARE Ratings Nepal Limited upgraded Sopan Pharmaceuticals Limited's rating from CARE-NP B- (Is) to CARE-NP B (Is), indicating a high risk of default.
